These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28699740)

  • 21. GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.
    Cannavo A; Koch WJ
    Cell Signal; 2018 Jan; 41():33-40. PubMed ID: 28077324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRK2 as a therapeutic target for heart failure.
    Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G
    Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.
    Homan KT; Waldschmidt HV; Glukhova A; Cannavo A; Song J; Cheung JY; Koch WJ; Larsen SD; Tesmer JJG
    J Biol Chem; 2015 Aug; 290(34):20649-20659. PubMed ID: 26032411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.
    Terao Y; Suzuki H; Yoshikawa M; Yashiro H; Takekawa S; Fujitani Y; Okada K; Inoue Y; Yamamoto Y; Nakagawa H; Yao S; Kawamoto T; Uchikawa O
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7326-9. PubMed ID: 23147077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.
    Bouley R; Waldschmidt HV; Cato MC; Cannavo A; Song J; Cheung JY; Yao XQ; Koch WJ; Larsen SD; Tesmer JJG
    Mol Pharmacol; 2017 Dec; 92(6):707-717. PubMed ID: 29070696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
    Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
    Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.
    Bandarage UK; Cao J; Come JH; Court JJ; Gao H; Jacobs MD; Marhefka C; Nanthakumar S; Green J
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2622-2626. PubMed ID: 30082069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics.
    Oguro Y; Cary DR; Miyamoto N; Tawada M; Iwata H; Miki H; Hori A; Imamura S
    Bioorg Med Chem; 2013 Aug; 21(15):4714-29. PubMed ID: 23755884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes.
    Fu Q; Xu B; Parikh D; Cervantes D; Xiang YK
    Cell Signal; 2015 Mar; 27(3):707-15. PubMed ID: 25460042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function.
    Vinge LE; Andressen KW; Attramadal T; Andersen GØ; Ahmed MS; Peppel K; Koch WJ; Freedman NJ; Levy FO; Skomedal T; Osnes JB; Attramadal H
    Mol Pharmacol; 2007 Sep; 72(3):582-91. PubMed ID: 17573483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Wang L; Liu X; Duan Y; Li X; Zhao B; Wang C; Xiao Z; Zheng P; Tang Q; Zhu W
    Chem Biol Drug Des; 2018 Jul; 92(1):1301-1314. PubMed ID: 29575727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.
    Hata JA; Williams ML; Schroder JN; Lima B; Keys JR; Blaxall BC; Petrofski JA; Jakoi A; Milano CA; Koch WJ
    J Card Fail; 2006 Jun; 12(5):360-8. PubMed ID: 16762799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitors.
    Hu Z; Wang C; Sitkoff D; Cheadle NL; Xu S; Muckelbauer JK; Adam LP; Wexler RR; Quan ML
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127474. PubMed ID: 32805407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors.
    Hayakawa M; Kawaguchi K; Kaizawa H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Parker P; Workman P; Waterfield MD
    Bioorg Med Chem; 2007 Sep; 15(17):5837-44. PubMed ID: 17601739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.
    Thal DM; Yeow RY; Schoenau C; Huber J; Tesmer JJ
    Mol Pharmacol; 2011 Aug; 80(2):294-303. PubMed ID: 21596927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.
    Chekanov MO; Ostrynska OV; Synyugin AR; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):338-43. PubMed ID: 23578312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.
    Wang Q; Liu Y; Fu Q; Xu B; Zhang Y; Kim S; Tan R; Barbagallo F; West T; Anderson E; Wei W; Abel ED; Xiang YK
    Circulation; 2017 Jan; 135(1):73-88. PubMed ID: 27815373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Tang Q; Wang L; Tu Y; Zhu W; Luo R; Tu Q; Wang P; Wu C; Gong P; Zheng P
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1680-4. PubMed ID: 26923692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
    Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.